Mary Theresa LaSalvia, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Daptomycin | 2 | 2018 | 71 | 0.690 |
Why?
|
| Vancomycin | 2 | 2018 | 504 | 0.500 |
Why?
|
| Diabetic Foot | 2 | 2022 | 382 | 0.270 |
Why?
|
| Anti-Bacterial Agents | 4 | 2022 | 7469 | 0.250 |
Why?
|
| Podiatry | 1 | 2022 | 28 | 0.210 |
Why?
|
| Osteomyelitis | 1 | 2022 | 408 | 0.150 |
Why?
|
| Infusions, Parenteral | 1 | 2018 | 395 | 0.150 |
Why?
|
| Pneumonia, Aspiration | 1 | 2017 | 145 | 0.130 |
Why?
|
| Microbiological Techniques | 1 | 2017 | 97 | 0.130 |
Why?
|
| Candida | 1 | 2017 | 171 | 0.130 |
Why?
|
| Equipment Contamination | 1 | 2017 | 183 | 0.120 |
Why?
|
| Sputum | 1 | 2017 | 514 | 0.120 |
Why?
|
| Endocarditis, Bacterial | 1 | 2018 | 436 | 0.120 |
Why?
|
| Candidiasis | 1 | 2017 | 366 | 0.110 |
Why?
|
| Actinomycetales | 1 | 2013 | 33 | 0.110 |
Why?
|
| Actinomycetales Infections | 1 | 2013 | 30 | 0.110 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2013 | 29 | 0.110 |
Why?
|
| Bacteria, Anaerobic | 1 | 2013 | 71 | 0.110 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2018 | 366 | 0.110 |
Why?
|
| Dialysis Solutions | 1 | 2013 | 33 | 0.110 |
Why?
|
| Peritoneal Dialysis | 1 | 2013 | 161 | 0.100 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 705 | 0.100 |
Why?
|
| Bacteremia | 1 | 2018 | 983 | 0.100 |
Why?
|
| Peritonitis | 1 | 2013 | 368 | 0.090 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 1009 | 0.090 |
Why?
|
| Outpatients | 1 | 2018 | 1600 | 0.090 |
Why?
|
| Communicable Diseases | 1 | 2018 | 872 | 0.080 |
Why?
|
| Abscess | 1 | 2013 | 606 | 0.080 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 2783 | 0.070 |
Why?
|
| Disease Outbreaks | 1 | 2017 | 1761 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2018 | 1907 | 0.070 |
Why?
|
| Antipsychotic Agents | 1 | 2017 | 3078 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 5886 | 0.060 |
Why?
|
| Logistic Models | 1 | 2018 | 13284 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15424 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 59548 | 0.040 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5716 | 0.040 |
Why?
|
| Retrospective Studies | 5 | 2022 | 81659 | 0.040 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2018 | 168 | 0.040 |
Why?
|
| Aged | 6 | 2018 | 171319 | 0.030 |
Why?
|
| Debridement | 1 | 2018 | 494 | 0.030 |
Why?
|
| Adult | 6 | 2018 | 223317 | 0.030 |
Why?
|
| Middle Aged | 5 | 2018 | 223233 | 0.030 |
Why?
|
| Male | 7 | 2018 | 364203 | 0.030 |
Why?
|
| DNA, Ribosomal | 1 | 2013 | 300 | 0.020 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 788 | 0.020 |
Why?
|
| Female | 7 | 2018 | 396660 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2017 | 1277 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2017 | 1429 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2013 | 1044 | 0.020 |
Why?
|
| Humans | 9 | 2022 | 767040 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2013 | 1477 | 0.020 |
Why?
|
| Wound Healing | 1 | 2018 | 2800 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 8535 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2018 | 24299 | 0.020 |
Why?
|
| Young Adult | 3 | 2017 | 59980 | 0.020 |
Why?
|
| Drug Hypersensitivity | 1 | 2013 | 903 | 0.010 |
Why?
|
| Length of Stay | 1 | 2018 | 6489 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2018 | 5345 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2018 | 3283 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 4780 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13646 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 17608 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 2495 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15925 | 0.010 |
Why?
|
| Hospitalization | 1 | 2017 | 10815 | 0.010 |
Why?
|
| Time Factors | 1 | 2018 | 40154 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2017 | 41718 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 65295 | 0.010 |
Why?
|
| United States | 1 | 2017 | 72971 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 89046 | 0.010 |
Why?
|